Your browser doesn't support javascript.
loading
MiR-139-5p Targetedly Regulates YAF2 and Mediates the AKT/P38 MAPK Signaling Pathway to Alleviate the Metastasis of Non-Small Cell Lung Cancer Cells and Their Resistance Against Cisplatin.
Yan, Yubo; Jin, Xiangyuan; Sun, HaoBo; Pang, Sainan; Kong, Xianglong; Bu, Jianlong; Xu, Shidong.
Afiliação
  • Yan Y; Department of Thoracic Surgery, Harbin Medical University Tumer Hospital, Harbin, Heilongjiang Province, 150000, People's Republic of China.
  • Jin X; Department of Thoracic Surgery, Harbin Medical University Tumer Hospital, Harbin, Heilongjiang Province, 150000, People's Republic of China.
  • Sun H; Department of Thoracic Surgery, Harbin Medical University Tumer Hospital, Harbin, Heilongjiang Province, 150000, People's Republic of China.
  • Pang S; Department of Thoracic Surgery, Harbin Medical University Tumer Hospital, Harbin, Heilongjiang Province, 150000, People's Republic of China.
  • Kong X; Department of Thoracic Surgery, Harbin Medical University Tumer Hospital, Harbin, Heilongjiang Province, 150000, People's Republic of China.
  • Bu J; Department of Thoracic Surgery, Harbin Medical University Tumer Hospital, Harbin, Heilongjiang Province, 150000, People's Republic of China.
  • Xu S; Department of Thoracic Surgery, Harbin Medical University Tumer Hospital, Harbin, Heilongjiang Province, 150000, People's Republic of China.
Cancer Manag Res ; 13: 3639-3650, 2021.
Article em En | MEDLINE | ID: mdl-33981163

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancer Manag Res Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancer Manag Res Ano de publicação: 2021 Tipo de documento: Article